DE69822208D1 - Osmotisches verabreichungssystem mit stöpselrückhaltemechanismus - Google Patents

Osmotisches verabreichungssystem mit stöpselrückhaltemechanismus

Info

Publication number
DE69822208D1
DE69822208D1 DE69822208T DE69822208T DE69822208D1 DE 69822208 D1 DE69822208 D1 DE 69822208D1 DE 69822208 T DE69822208 T DE 69822208T DE 69822208 T DE69822208 T DE 69822208T DE 69822208 D1 DE69822208 D1 DE 69822208D1
Authority
DE
Germany
Prior art keywords
pushroom
administration system
restraint mechanism
osmotic administration
osmotic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69822208T
Other languages
English (en)
Other versions
DE69822208T2 (de
Inventor
Rupal Ayer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Intarcia Therapeutics Inc
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Publication of DE69822208D1 publication Critical patent/DE69822208D1/de
Application granted granted Critical
Publication of DE69822208T2 publication Critical patent/DE69822208T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
DE69822208T 1997-12-29 1998-12-15 Osmotisches verabreichungssystem mit stöpselrückhaltemechanismus Expired - Lifetime DE69822208T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US6898797P 1997-12-29 1997-12-29
US68987P 1997-12-29
PCT/US1998/026654 WO1999033446A1 (en) 1997-12-29 1998-12-15 Osmotic delivery system with membrane plug retention mechanism

Publications (2)

Publication Number Publication Date
DE69822208D1 true DE69822208D1 (de) 2004-04-08
DE69822208T2 DE69822208T2 (de) 2005-04-28

Family

ID=22085978

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69822208T Expired - Lifetime DE69822208T2 (de) 1997-12-29 1998-12-15 Osmotisches verabreichungssystem mit stöpselrückhaltemechanismus

Country Status (13)

Country Link
US (5) US6270787B1 (de)
EP (1) EP1041968B1 (de)
JP (1) JP4173635B2 (de)
AR (1) AR014194A1 (de)
AT (1) ATE260640T1 (de)
AU (1) AU1828599A (de)
CA (1) CA2316976C (de)
DE (1) DE69822208T2 (de)
ES (1) ES2217613T3 (de)
HK (1) HK1031332A1 (de)
TW (1) TW446552B (de)
WO (1) WO1999033446A1 (de)
ZA (1) ZA9811880B (de)

Families Citing this family (101)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY125870A (en) * 1997-07-25 2006-08-30 Alza Corp Osmotic delivery system flow modulator apparatus and method
DE69822208T2 (de) * 1997-12-29 2005-04-28 Alza Corp., Mountain View Osmotisches verabreichungssystem mit stöpselrückhaltemechanismus
CA2356860C (en) * 1998-12-31 2006-11-07 Alza Corporation Osmotic delivery system having space efficient piston
US7258869B1 (en) * 1999-02-08 2007-08-21 Alza Corporation Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicle
US7919109B2 (en) 1999-02-08 2011-04-05 Intarcia Therapeutics, Inc. Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicles
DE60023361T2 (de) * 1999-12-21 2006-04-27 Alza Corp., Mountain View Ventil für osmotische vorrichtungen
US7163688B2 (en) * 2001-06-22 2007-01-16 Alza Corporation Osmotic implant with membrane and membrane retention means
US7927613B2 (en) * 2002-02-15 2011-04-19 University Of South Florida Pharmaceutical co-crystal compositions
US7790905B2 (en) * 2002-02-15 2010-09-07 Mcneil-Ppc, Inc. Pharmaceutical propylene glycol solvate compositions
US20100311701A1 (en) * 2002-02-15 2010-12-09 Transform Pharmaceuticals, Inc Pharmaceutical Co-Crystal Compositions
IL163846A0 (en) * 2002-03-01 2005-12-18 Univ South Florida Multiple-component solid phases containing at least one active pharmaceutical ingredient
CN1668279A (zh) * 2002-06-17 2005-09-14 阿尔萨公司 具有包含分散在液体载体中的渗透物质的早期零级推动力动力系统的渗透递送体系
JP2006500377A (ja) * 2002-06-21 2006-01-05 トランスフォーム・ファーマシューティカルズ・インコーポレイテッド 改善された溶解性を有する医薬組成物
ATE376854T1 (de) 2002-06-26 2007-11-15 Alza Corp Minimal nachgiebiger volumen-effizienter kolben für osmotische medikamentenabgabesysteme
US7014636B2 (en) * 2002-11-21 2006-03-21 Alza Corporation Osmotic delivery device having a two-way valve and a dynamically self-adjusting flow channel
BR0317421A (pt) * 2002-12-19 2005-11-08 Alza Corp Géis de fase única não-aquosa estável e formulações destes para liberação a partir de um dispositivo implantável
US7731947B2 (en) * 2003-11-17 2010-06-08 Intarcia Therapeutics, Inc. Composition and dosage form comprising an interferon particle formulation and suspending vehicle
US8183290B2 (en) 2002-12-30 2012-05-22 Mcneil-Ppc, Inc. Pharmaceutically acceptable propylene glycol solvate of naproxen
EP2339328A3 (de) 2002-12-30 2011-07-13 Transform Pharmaceuticals, Inc. Pharmazeutische kokristallisierte Celecoxib-Zusammensetzungen
CA2513746C (en) 2003-02-28 2012-08-28 Transform Pharmaceuticals, Inc. Pharmaceutical co-crystal compositions of drugs such as carbamazeptine, celecoxib, olanzapine, itraconazole, topiramate, modafinil, 5-fluorouracil, hydrochlorothiazide, acetaminophen, aspirin, flurbiprofen, phenytoin and ibuprofen
JP2006521897A (ja) * 2003-03-31 2006-09-28 アルザ・コーポレーション 内部圧力を放散する手段を備える浸透ポンプ
KR20060002922A (ko) 2003-03-31 2006-01-09 알자 코포레이션 비수성 단일 상 비히클 및 이러한 비히클을 이용한 제형
AU2004227986A1 (en) * 2003-03-31 2004-10-21 Alza Corporation Osmotic delivery system and method for decreasing start-up times for osmotic delivery systems
WO2004091278A2 (en) * 2003-04-11 2004-10-28 Transform Pharmaceuticals, Inc. Gabapentin compositions
WO2005000786A1 (en) 2003-05-23 2005-01-06 Transform Pharmaceuticals, Inc. Sertraline compositions
AU2004275835B2 (en) 2003-09-26 2011-06-23 Alza Corporation Controlled release formulations exhibiting an ascending rate of release
WO2005030166A1 (en) * 2003-09-26 2005-04-07 Alza Corporation Oros push-stick for controlled delivery of active agents
MXPA06003450A (es) 2003-09-26 2006-08-31 Johnson & Johnson Recubrimiento de farmaco que proporciona alta carga del farmaco y metodos para proporcionar el mismo.
US20050158382A1 (en) * 2003-09-26 2005-07-21 Evangeline Cruz Controlled release formulations of opioid and nonopioid analgesics
BRPI0414941A (pt) * 2003-09-30 2006-11-07 Alza Corp dispositivo de distribuição de agente ativo acionado osmoticamente proporcionando um perfil de liberação ascendente
CA2537811A1 (en) * 2003-10-31 2005-05-19 Alza Corporation Osmotic pump with self-retaining, fast-start membrane plug
US20050113410A1 (en) * 2003-11-03 2005-05-26 Mark Tawa Pharmaceutical salts of zafirlukast
CA2545027A1 (en) * 2003-11-06 2005-05-26 Alza Corporation Modular imbibition rate reducer for use with implantable osmotic pump
AU2004293013B2 (en) 2003-11-19 2011-04-28 Metabasis Therapeutics, Inc. Novel phosphorus-containing thyromimetics
WO2005092065A2 (en) * 2004-03-25 2005-10-06 Transform Pharmaceuticals, Inc. Novel tricyclic compounds and related methods of treatment
US20080022287A1 (en) * 2004-03-31 2008-01-24 Koninklijke Philips Electronics, N.V. Method And System For Transferring Budgets In A Technique For Restrained Budget Use
US20050266087A1 (en) * 2004-05-25 2005-12-01 Gunjan Junnarkar Formulations having increased stability during transition from hydrophobic vehicle to hydrophilic medium
JP5017103B2 (ja) * 2004-06-17 2012-09-05 トランスフオーム・フアーマシユーチカルズ・インコーポレーテツド 薬剤共結晶組成物および関連した使用方法
US8518022B2 (en) 2004-08-27 2013-08-27 Medimetrics Personalized Drug Delivery, Inc. Electronically and remotely controlled pill and system for delivering at least one medicament
US8541026B2 (en) * 2004-09-24 2013-09-24 Abbvie Inc. Sustained release formulations of opioid and nonopioid analgesics
US8779175B2 (en) 2004-10-25 2014-07-15 Synthonics, Inc. Coordination complexes, pharmaceutical solutions comprising coordination complexes, and methods of treating patients
US20060160783A1 (en) * 2004-12-30 2006-07-20 Transform Pharmaceuticals, Inc. Novel omeprazole forms and related methods
US11246913B2 (en) 2005-02-03 2022-02-15 Intarcia Therapeutics, Inc. Suspension formulation comprising an insulinotropic peptide
EP2361630A1 (de) * 2005-02-03 2011-08-31 Intarcia Therapeutics, Inc Implantierbares Arzneimittelfreigabesystem Partikel und eine osmotische Pumpe enthaltend
WO2006083761A2 (en) 2005-02-03 2006-08-10 Alza Corporation Solvent/polymer solutions as suspension vehicles
US7959938B2 (en) 2005-03-15 2011-06-14 Intarcia Therapeutics, Inc. Polyoxaester suspending vehicles for use with implantable delivery systems
WO2007005680A1 (en) * 2005-06-30 2007-01-11 Alza Corporation Osmotic intraosseous drug delivery system
US20070027105A1 (en) 2005-07-26 2007-02-01 Alza Corporation Peroxide removal from drug delivery vehicle
US7931620B2 (en) * 2006-02-01 2011-04-26 Roche Diagnostics International Ag Self-sealing connection for housing shells of an administering device
US20090198220A1 (en) * 2006-04-28 2009-08-06 Michel Paul Barbara Van Bruggen Osmotic pump with at least one chargeable material
CN101453982B (zh) * 2006-05-30 2011-05-04 精达制药公司 两件式内部通道渗透递送系统流动调节器
ES2422864T3 (es) * 2006-08-09 2013-09-16 Intarcia Therapeutics, Inc Sistemas de liberación osmótica y unidades de pistón
US9114133B2 (en) 2006-08-25 2015-08-25 U.S. Dept. Of Veterans Affairs Method of improving diastolic dysfunction
US8617143B2 (en) * 2006-12-07 2013-12-31 The Regents Of The University Of California Therapeutic agent delivery systems and devices
AU2008212816B2 (en) 2007-02-09 2014-08-07 Metabasis Therapeutics, Inc. Novel antagonists of the glucagon receptor
RU2440097C2 (ru) 2007-04-23 2012-01-20 Интарсия Терапьютикс, Инк. Способ лечения диабета ii типа и ожирения, осмотическое устройство для доставки и способ его изготовления
MX2010001071A (es) * 2007-07-27 2010-03-09 Depomed Inc Formas de dosificacion retentivas gastricas pulsatiles.
BRPI0815557A2 (pt) 2007-08-13 2015-02-18 Metabasis Therapeuticas Inc Atividaores de glicocinase
US9226907B2 (en) 2008-02-01 2016-01-05 Abbvie Inc. Extended release hydrocodone acetaminophen and related methods and uses thereof
EP2240155B1 (de) 2008-02-13 2012-06-06 Intarcia Therapeutics, Inc Vorrichtungen, formulierungen und verfahren zur freisetzung mehrerer wirkstoffe
KR101599089B1 (ko) 2008-08-13 2016-03-02 메타베이시스 테라퓨틱스, 인크. 글루카곤 길항제
NZ592113A (en) * 2008-10-15 2012-04-27 Intarcia Therapeutics Inc Highly concentrated drug particles, formulations, suspensions and uses thereof
BRPI1006765A2 (pt) 2009-04-07 2019-03-26 Koninl Philips Electronics Nv cápsula ingerível para a liberação de uma droga
US10046109B2 (en) 2009-08-12 2018-08-14 Progenity, Inc. Drug delivery device with compressible drug reservoir
EP3323423B1 (de) * 2009-09-28 2020-06-17 Intarcia Therapeutics, Inc Schnelle initiierung und/oder beendigung der verabreichung substantiell stabiler arzneimittel
CN102884072A (zh) 2010-04-08 2013-01-16 爱默蕾大学 被取代的雄甾-4-烯二酮
EP2611369A2 (de) 2010-08-30 2013-07-10 Sinusys Corporation Vorrichtungen zu dilatation einer paranasalen sinusöffnung und zur behandlung von sinusitis
US20120208755A1 (en) 2011-02-16 2012-08-16 Intarcia Therapeutics, Inc. Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
CA2830069C (en) 2011-03-20 2019-11-12 The University Of British Columbia Therapeutic agent for emphysema and copd
WO2012129497A2 (en) * 2011-03-24 2012-09-27 MEDIMETRICS Personalized Drug Delivery B.V. Swallowable medication capsule
ITFI20110114A1 (it) 2011-05-31 2012-12-01 Scuola Superiore Di Studi Universit Arie Di Perfe Piattaforma robotica per chirurgia mininvasiva
US20140227293A1 (en) 2011-06-30 2014-08-14 Trustees Of Boston University Method for controlling tumor growth, angiogenesis and metastasis using immunoglobulin containing and proline rich receptor-1 (igpr-1)
US20130090633A1 (en) * 2011-10-07 2013-04-11 University Of Southern California Osmotic patch pump
TWI615155B (zh) * 2011-11-01 2018-02-21 拜耳股份有限公司 滲透活性的陰道遞送系統
US9138569B2 (en) 2012-02-29 2015-09-22 SinuSys Corporation Devices and methods for dilating a paranasal sinus opening and for treating sinusitis
US9737364B2 (en) 2012-05-14 2017-08-22 Vanderbilt University Local magnetic actuation of surgical devices
EP2852595B1 (de) 2012-05-21 2016-06-22 Bayer Pharma Aktiengesellschaft Substituierte benzothienpyrimidine
US9826904B2 (en) 2012-09-14 2017-11-28 Vanderbilt University System and method for detecting tissue surface properties
US20140081169A1 (en) * 2012-09-17 2014-03-20 Vanderbilt University System and method of tetherless insufflation in colon capsule endoscopy
TW201412740A (zh) 2012-09-20 2014-04-01 Bayer Pharma AG 經取代之吡咯并嘧啶胺基苯并噻唑酮
CN102871982B (zh) 2012-10-16 2014-09-10 中国科学院上海药物研究所 一种药物渗透泵制剂
US10485409B2 (en) 2013-01-17 2019-11-26 Vanderbilt University Real-time pose and magnetic force detection for wireless magnetic capsule
US9687263B2 (en) 2013-05-30 2017-06-27 SinuSys Corporation Devices and methods for inserting a sinus dilator
CA2924141C (en) 2013-08-22 2022-06-07 The General Hospital Corporation 5-amino 4-cyano substituted oxazole and thiazole derivatives as inhibitors of human 12/15-lipoxygenase
EP3154956A4 (de) 2014-06-12 2018-01-17 Ligand Pharmaceuticals, Inc. Glucagonantagonisten
US10758111B2 (en) 2014-09-09 2020-09-01 Vanderbilt University Hydro-jet endoscopic capsule and methods for gastric cancer screening in low resource settings
US9889085B1 (en) 2014-09-30 2018-02-13 Intarcia Therapeutics, Inc. Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
EP3302354B1 (de) 2015-06-03 2023-10-04 i2o Therapeutics, Inc. Systeme zum einsetzen eines implantats
JP7037490B2 (ja) 2015-11-05 2022-03-16 ザ ジェネラル ホスピタル コーポレイション 副腎脊髄ニューロパチーの治療のためのａｂｃｄ１をコードする核酸配列の髄腔内送達
WO2017200943A1 (en) 2016-05-16 2017-11-23 Intarcia Therapeutics, Inc. Glucagon-receptor selective polypeptides and methods of use thereof
USD840030S1 (en) 2016-06-02 2019-02-05 Intarcia Therapeutics, Inc. Implant placement guide
USD860451S1 (en) 2016-06-02 2019-09-17 Intarcia Therapeutics, Inc. Implant removal tool
CA3040906A1 (en) 2016-10-20 2018-04-26 Peptron, Inc. Methods of delivering a neuroprotective polypeptide to the central nervous system
KR20190104039A (ko) 2017-01-03 2019-09-05 인타르시아 세라퓨틱스 인코포레이티드 Glp-1 수용체 효능제의 연속적인 투여 및 약물의 동시-투여를 포함하는 방법
AU2018231249A1 (en) 2017-03-08 2019-09-26 Intarcia Therapeutics, Inc Apparatus and methods for administration of a nauseogenic compound from a drug delivery device
US11122965B2 (en) 2017-10-09 2021-09-21 Vanderbilt University Robotic capsule system with magnetic actuation and localization
USD933219S1 (en) 2018-07-13 2021-10-12 Intarcia Therapeutics, Inc. Implant removal tool and assembly
BR112021006823A2 (pt) 2018-10-11 2021-07-27 Intarcia Therapeutics, Inc. polipeptídeos análogos de amilina humana e métodos de uso
US20200155466A1 (en) * 2018-11-21 2020-05-21 II Don S. Houtz Oral Medicine Delivery Capsule
CN109589491B (zh) * 2019-01-29 2024-01-09 上海安翰医疗技术有限公司 自动给药装置
CA3167217A1 (en) 2020-01-13 2021-07-22 Durect Corporation Sustained release drug delivery systems with reduced impurities and related methods

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3995631A (en) 1971-01-13 1976-12-07 Alza Corporation Osmotic dispenser with means for dispensing active agent responsive to osmotic gradient
US3732865A (en) 1971-01-13 1973-05-15 Alza Corp Osmotic dispenser
US3845770A (en) 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
US3929132A (en) 1973-04-10 1975-12-30 Alza Corp Osmotic dispenser
US3995632A (en) 1973-05-04 1976-12-07 Alza Corporation Osmotic dispenser
US3916889A (en) 1973-09-28 1975-11-04 Sandoz Ag Patient ventilator apparatus
US3888249A (en) * 1973-11-02 1975-06-10 David L Spencer Arterial infusion catheter
US4203439A (en) 1976-11-22 1980-05-20 Alza Corporation Osmotic system with volume amplifier for increasing amount of agent delivered therefrom
US4111203A (en) 1976-11-22 1978-09-05 Alza Corporation Osmotic system with means for improving delivery kinetics of system
US4111202A (en) 1976-11-22 1978-09-05 Alza Corporation Osmotic system for the controlled and delivery of agent over time
US4243030A (en) 1978-08-18 1981-01-06 Massachusetts Institute Of Technology Implantable programmed microinfusion apparatus
US4373527B1 (en) 1979-04-27 1995-06-27 Univ Johns Hopkins Implantable programmable medication infusion system
US4340054A (en) 1980-12-29 1982-07-20 Alza Corporation Dispenser for delivering fluids and solids
US4439196A (en) 1982-03-18 1984-03-27 Merck & Co., Inc. Osmotic drug delivery system
US4552561A (en) 1982-12-23 1985-11-12 Alza Corporation Body mounted pump housing and pump assembly employing the same
US4639244A (en) 1983-05-03 1987-01-27 Nabil I. Rizk Implantable electrophoretic pump for ionic drugs and associated methods
US4865845A (en) 1986-03-21 1989-09-12 Alza Corporation Release rate adjustment of osmotic or diffusional delivery devices
US4874388A (en) 1987-06-25 1989-10-17 Alza Corporation Multi-layer delivery system
US5151093A (en) 1990-10-29 1992-09-29 Alza Corporation Osmotically driven syringe with programmable agent delivery
GB9027422D0 (en) 1990-12-18 1991-02-06 Scras Osmotically driven infusion device
US5137727A (en) 1991-06-12 1992-08-11 Alza Corporation Delivery device providing beneficial agent stability
US5223265A (en) 1992-01-10 1993-06-29 Alza Corporation Osmotic device with delayed activation of drug delivery
US5308348A (en) 1992-02-18 1994-05-03 Alza Corporation Delivery devices with pulsatile effect
US5456679A (en) 1992-02-18 1995-10-10 Alza Corporation Delivery devices with pulsatile effect
NZ288144A (en) * 1994-06-22 1998-12-23 Unasco Pty Active agent sustained release capsule: fluid expandable layers and active agent layers
US5731001A (en) * 1995-06-07 1998-03-24 Magruder; Judy A. Locking couplings for osmotic delivery devices
RU2189221C2 (ru) 1996-02-02 2002-09-20 Элзэ Копэрейшн Устройство для введения активного вещества (варианты), способ его изготовления и способ лечения пациента, страдающего раком предстательной железы
DE69822208T2 (de) * 1997-12-29 2005-04-28 Alza Corp., Mountain View Osmotisches verabreichungssystem mit stöpselrückhaltemechanismus
JP4494629B2 (ja) * 1997-12-30 2010-06-30 インターシア セラピューティクス，インコーポレイティド メンブレンプラグを備えた有益な作用剤の供給システム

Also Published As

Publication number Publication date
US6270787B1 (en) 2001-08-07
JP2001526939A (ja) 2001-12-25
AR014194A1 (es) 2001-02-07
EP1041968A1 (de) 2000-10-11
AU1828599A (en) 1999-07-19
US20040243106A1 (en) 2004-12-02
ZA9811880B (en) 1999-06-29
ATE260640T1 (de) 2004-03-15
US6976981B2 (en) 2005-12-20
HK1031332A1 (en) 2001-06-15
TW446552B (en) 2001-07-21
CA2316976C (en) 2009-02-17
US20050048097A1 (en) 2005-03-03
WO1999033446A1 (en) 1999-07-08
ES2217613T3 (es) 2004-11-01
US20010022974A1 (en) 2001-09-20
US20010021822A1 (en) 2001-09-13
JP4173635B2 (ja) 2008-10-29
CA2316976A1 (en) 1999-07-08
US6899887B2 (en) 2005-05-31
EP1041968B1 (de) 2004-03-03
DE69822208T2 (de) 2005-04-28

Similar Documents

Publication Publication Date Title
DE69822208D1 (de) Osmotisches verabreichungssystem mit stöpselrückhaltemechanismus
DE69837439D1 (de) Osmotisches verabreichungssystem mit semipermeablem stöpsel
PT1051217E (pt) Sistema de controlo osmotico de administracao de medicamento
DE69810445D1 (de) Sitzbelegung-feststellungssystem
ATE259409T1 (de) Abgabesystem mit ablösesperrschicht beladenen zeolite
FI943168A0 (fi) Opioidiformulaatioita, joissa on pitkitetty säädelty vapautuminen
ATE291417T1 (de) Gastrointestinales wirkstoffverabreichungssystem
DK1030817T3 (da) Brændstofdispenseringssystem
ATE293816T1 (de) Sicherheitsvorrichtung mit mehreren sicherheitsmerkmalen
DE69822529D1 (de) Stentanbringungssystem
DK0862082T3 (da) Multiprojektionsystem
NO20001776L (no) Medikamenter
ID21702A (id) Sistim dispenser
DK0998272T3 (da) Farmaceutisk præparat til kombinationen piperidinoalkanoldekongestivum
DE59706916D1 (de) Rückhaltesystem
DE69818738D1 (de) Abwickelsystem mit Zentralantrieb
DE69829254D1 (de) Arzneistoffzubereitung mit kontrollierter Wirkstofffreisetzungsrate
NL1006015A1 (nl) Toedieninrichting.
DE69800089T2 (de) Abgabesysteme
DE29713252U1 (de) Systemschacht
DE29708900U1 (de) Schankanlage
NL1009232A1 (nl) Projectiesysteem.
KR970039307U (ko) 스플릿타입 리어시트백의 이중 로킹장치
SE9704104D0 (sv) Bilbältessystem
ES1034776Y (es) Mecanismo expositor secuencial.

Legal Events

Date Code Title Description
8332 No legal effect for de
8370 Indication related to discontinuation of the patent is to be deleted
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: INTARCIA THERAPEUTICS, INC., HAYWARD, CA, US